Mesa Laboratories, Inc. · Technology · Scientific & Technical Instruments
Scores & Status Key
AI Summary Scores: Intraday / Swing / Long scores are synthesized from multi-factor analysis for each timeframe. They summarize current conditions discussed in the report and do not constitute trading recommendations.
Intraday Trend Score: A 0–100 composite from the Trend Explorer™ analytics engine used for ranking and comparison. It describes current conditions and is not a forecast.
Trend Status: A rules-based label (Bullish / Mixed / Bearish) derived from signal confluence (trend structure, momentum, and positioning). It indicates alignment, not expected return.
At close
$96.57
−$0.00 (−0.00%) Close
Prev closePrevC$96.57
OpenOpen$96.52
Day highHigh$96.57
Day lowLow$96.52
VolumeVol120,724
Avg volAvgVol86,450
On chart
Interval
Intervals apply to 1D & 5D.
Intervals apply to 1D & 5D.
Scale: Linear
Overlays
Panels
Style
Scale: Linear
Presets
Tools
Tickers only (no ^ indexes). Add up to 5.
Mkt cap
$533.53M
P/E ratio
148.57
FY Revenue
$247.54M
EPS
0.65
Gross Margin
62.40%
Sector
Technology
AI report sections
BULLISH
MLAB
Mesa Laboratories, Inc.
No AI report section text found yet for this symbol.
Volume vs average
Intraday (cumulative)
+58% (Above avg)
Vol/Avg: 1.58×
RSI
63.82(Strong)
Strong (60–70)
0255075100
MACD momentum
Intraday
+0.04 (Strong)
MACD: 0.18 Signal: 0.14
Short-Term
+0.36 (Strong)
MACD: 2.87 Signal: 2.51
Long-Term
+0.49 (Strong)
MACD: 4.07 Signal: 3.58
Intraday trend score
74.00
LOW56.00HIGH78.00
Latest news
MLAB•12 articles•Positive: 3Neutral: 1Negative: 0
NeutralGlobeNewswire Inc.• Mesa Laboratories, Inc.
MESA LABS DECLARES QUARTERLY DIVIDEND
Mesa Laboratories announced a quarterly dividend of $0.16 per share, payable on September 15, 2025, to shareholders of record as of August 29, 2025.
MLABdividendquarterlyshareholdersfinancialNASDAQ
Sentiment note
Standard routine dividend announcement with no significant positive or negative indicators, representing typical corporate financial communication
PositiveGlobeNewswire Inc.• N/A
MESA LABS DECLARES QUARTERLY DIVIDEND
Mesa Laboratories, Inc. (MLAB) announced a regular quarterly dividend of $0.16 per share, payable on June 16, 2025. The company is a global leader in life science tools and quality control solutions for the pharmaceutical, healthcare, and medical device industries.
MLABMesa Laboratoriesdividendlife science toolsquality control
Sentiment note
The company announced a regular quarterly dividend, which is a positive sign for shareholders and indicates the company's financial stability and confidence in its future performance.
PositiveGlobeNewswire Inc.• N/A
Mesa Labs Announces Second Quarter Results
Mesa Laboratories, Inc. reported its second quarter fiscal year 2025 results, with revenues increasing 8.8% year-over-year. The company's Biopharmaceutical Development and Calibration Solutions divisions saw strong growth, while the Clinical Genomics division faced headwinds in China and North America.
The company reported strong overall revenue growth and profitability, with the Biopharmaceutical Development and Calibration Solutions divisions performing well.
PositiveGlobeNewswire Inc.• N/A
MESA LABS DECLARES QUARTERLY DIVIDEND
Mesa Laboratories, Inc. (NASDAQ:MLAB) announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock, payable on December 16, 2024, to shareholders of record at the close of business on November 29, 2024.
MLABMesa Laboratoriesdividendquarterly
Sentiment note
The company is declaring a regular quarterly dividend, which is a positive sign for shareholders and indicates the company's financial stability and confidence in its future performance.
UnknownGlobeNewswire Inc.• Mesa Laboratories, Inc.
Mesa Labs Announces Fourth Quarter and Full Fiscal Year 2024 Results
LAKEWOOD, Colo., June 05, 2024 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB), a global leader in the design and manufacture of life science tools and critical quality control solutions, today announced results for its fourth fiscal quarter (“4Q24”) and fiscal year (“FY24”) ended March 31, 2024 (amounts in thousands).
MLABEarnings Releases and Operating Results
UnknownGlobeNewswire Inc.• Mesa Laboratories, Inc.
Mesa Laboratories, Inc. Revises Earnings Announcement date for Unaudited Fourth Quarter and Full Fiscal Year 2024 Results
LAKEWOOD, Colo., May 31, 2024 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (“Mesa”) (NASDAQ:MLAB) will not issue its 2024 financial results for the fourth quarter and the fiscal year ending March 31, 2024 today as previously communicated. The earnings announcement has been delayed as we work to finalize our year end audit which is focused on finalizing the calculations and technical accounting for previously-announced impairments of long-lived assets and goodwill related to our Clinical Genomics and Biopharmaceutical Development divisions and the purchase accounting associated with the acquisition of GKE.
MLABCompany Announcement
UnknownGlobeNewswire Inc.• Mesa Laboratories, Inc.
Mesa Laboratories, Inc. Revises Earnings Announcement date for Unaudited Fourth Quarter and Full Fiscal Year 2024 Results to May 31, 2024
LAKEWOOD, Colo., May 22, 2024 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (“Mesa”) (NASDAQ:MLAB) will issue a press release with financial results for the fourth quarter and the fiscal year ending March 31, 2024 at approximately 8:00 A.M. Eastern time on Friday, May 31, 2024. Mesa’s Form 10-K will be filed the same day. The earnings announcement has been delayed as we finalize the calculations and technical accounting for previously-announced impairments of long-lived assets and goodwill related to our Clinical Genomics and Biopharmaceutical Development divisions.
MLABCompany AnnouncementCalendar of Events
UnknownZacks Investment Research• Zacks Equity Research
DarioHealth (DRIO) delivered earnings and revenue surprises of 66.10% and 3.23%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
DRIOMLAB
UnknownZacks Investment Research• Zacks Equity Research
Neuronetics (STIM) delivered earnings and revenue surprises of 18.18% and 1.85%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
STIMMLAB
UnknownZacks Investment Research• Zacks Equity Research
Best Value Stocks to Buy for April 8th
SM and MLAB made it to the Zacks Rank #1 (Strong Buy) value stocks list on April 8, 2023.
SMMLAB
UnknownGlobeNewswire Inc.• Mesa Laboratories, Inc.
MESA LABS DECLARES QUARTERLY DIVIDEND
LAKEWOOD, Colo., April 04, 2024 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock. The dividend will be payable on June 14, 2024, to shareholders of record at the close of business on May 31, 2024.
MLABCompany Announcement
UnknownGlobeNewswire Inc.• Mesa Laboratories, Inc.
Mesa Laboratories, Inc. to Announce Unaudited Fourth Quarter and Full Fiscal Year 2024 Results on May 24, 2024
LAKEWOOD, Colo., April 01, 2024 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) will issue a press release with financial results for the fourth quarter and the fiscal year ending March 31, 2024 at approximately 8:00 A.M. Eastern time on Friday, May 24, 2024.
MLABCompany Announcement
News and sentiment labels describe article tone and are provided for research purposes only. They are not trading recommendations or forecasts.
Trade Ranks App
Trade Ranks, LLC is not a registered investment adviser or broker-dealer. All rankings and AI reports are for informational and educational purposes only and are not personalized advice. Investing involves risk. Policy Portal
